Bryn Mawr Trust CO Adma Biologics, Inc. Transaction History
Bryn Mawr Trust CO
- $4.09 Billion
- Q3 2025
A detailed history of Bryn Mawr Trust CO transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 385 shares of ADMA stock, worth $5,990. This represents 0.0% of its overall portfolio holdings.
Number of Shares
385
Previous 559
31.13%
Holding current value
$5,990
Previous $8,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
401Shares Held
205MCall Options Held
3.06MPut Options Held
1.88M-
Vanguard Group Inc Valley Forge, PA21MShares$326 Million0.0% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$290 Million0.0% of portfolio
-
State Street Corp Boston, MA13.6MShares$211 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.5MShares$195 Million0.03% of portfolio
-
Sachem Head Capital Management LP New York, NY8.96MShares$139 Million5.63% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.06B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...